AC IMMUNE SA SF-02 (IMR) — Net Asset Momentum

Latest YoY growth as of December 2025: -60.0%

AC IMMUNE SA SF-02 (IMR) recorded a net asset momentum of -60.0% as of December 2025, with net assets of €44.88 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See AC IMMUNE SA SF-02 liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

YoY Momentum

-60.0%
Year-over-year

Current Net Assets

€44.88 Million
EUR · December 2025

Years of Data

5
2021 – 2025

Country

Germany
F

AC IMMUNE SA SF-02 Net Asset Momentum (2021–2025)

This chart tracks AC IMMUNE SA SF-02's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -60.0%, with net assets of €44.88 Million EUR as of December 2025. Read total liabilities of AC IMMUNE SA SF-02 for a breakdown of total debt and financial obligations.

Annual Net Asset History for AC IMMUNE SA SF-02 (2021–2025)

The table below shows the complete annual net asset history for AC IMMUNE SA SF-02 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market cap of AC IMMUNE SA SF-02.

Year Net Assets (EUR) Total Assets Total Liabilities YoY Momentum
2025 €44.88 Million €154.25 Million €109.37 Million ▼ -60.0%
2024 €112.27 Million €230.91 Million €118.64 Million ▼ -30.1%
2023 €160.64 Million €182.81 Million €22.17 Million ▼ -4.9%
2022 €168.99 Million €185.94 Million €16.95 Million ▼ -27.2%
2021 €231.98 Million €261.44 Million €29.46 Million